Patents Assigned to Guangzhou Virotech Phamaceutical Co., Ltd.
  • Use of IAP inhibitor and oncolytic virus in preparation of anti-tumor drug
    Patent number: 10980850
    Abstract: Described herein is use of a Caspase activator and an oncolytic virus in the preparation of an anti-tumor drug. As described, Caspase activator can enhance the anti-tumor effect of oncolytic virus, and the combination of Caspase activator and oncolytic virus produces a significant synergistic anti-tumor effect, and demonstrates an effective therapy for the treatment of tumors that are less sensitive to other pharmaceutical treatments.
    Type: Grant
    Filed: August 18, 2017
    Date of Patent: April 20, 2021
    Assignee: Guangzhou Virotech Phamaceutical Co., Ltd.
    Inventors: Guangmei Yan, Jing Cai, Yuan Lin, Haipeng Zhang, Suizhen Lin, Shoufang Gong, Jun Hu, Xiao Xiao, Kai Li, Jiankai Liang, Yaqian Tan, Wenbo Zhu, Wei Yin